Login

Houlihan Lokey CEO Scott Beiser celebrates the firm's IPO at the NYSE, discussing M&A activity and key trends in restructuring. 00:10:00

Share On Facebook Share On Twitter

Scott Beiser is a Co-Chairman of Houlihan Lokey

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
From Sitcoms to Investment Management: Robert Stoll's Journey | Robert Stoll, CIO, Financial Design Studio.
00:10:00
Live Without a Cell Phone or TV: What's Your Choice?
00:10:00
Andrew Sales on AML3D’s Strategic Partnerships and Key Contract with Boeing | Ryan Millar , CEO, AML3D Ltd.
00:10:00
We help our customers and clients plan and achieve their most important financial goals by delivering innovative products and services through intuitive digital experiences | Abigail Johnson,Chairman and CEO,Fidelity Advisor Sustainable Multi-Asset Fund
00:10:00
Strategic Moves Fuel Birkenstock’s Valuation Surge | Nikhil Thukral, Managing partner,  L Catterton.
00:10:00
Powering the Future: The MEGA10 Fund’s Strategic Investment in the World’s Top 10 Companies | Talis Asset Management - Fund Manager, MEGA10
00:10:00
Peterson We Services Discusses Market Volatility and Long-Term Investment Strategies
00:10:00
Economic Recession Trends: From Historical Convulsions to Modern Stability|Taylor and Judd
00:10:00
Bill Rancic and Mark Reisenauer Talk About the C3 Award for Cancer Innovation | Mark Reisenauer, PRESIDENT, ASTELLAS PHARMA US, INC
00:10:00
GoldSource Mines: Advancing the High-Return Eagle Mountain Gold Project in Guyana
00:10:00
Sean Roosen Discusses Ascot Development and Strategic Vision in Mining
00:10:00
Eleco's Interim CEO Jonathan Hunter Highlights Resilient H1 Results and Future Opportunities in €10 Trillion Construction Industry | Jonathan Hunter , CEO of elecosoft plc

© 2017 - Neuhu+